Annette Bruls - 28 Aug 2026 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Reporting relationship: CVP, EMEACLA
Issuer ticker: EW
Reported as of: 28 Aug 2026
Net transaction value: -$237,907
SEC form: 4
Accepted by SEC: 28 Aug 2026, 16:32:52 UTC
Prior SEC filing: 13 Jul 2026
Source filing: View source filing
Reporting owner signature: Linda J. Park, Attorney-in-Fact

Key filing fact

Annette Bruls filed Form 4 for Edwards Lifesciences Corp (EW) on 28 Aug 2026.

Key facts

This page summarizes Annette Bruls's Form 4 filing for Edwards Lifesciences Corp (EW).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 28 Aug 2026, 16:32.

Change

Previous filing in this sequence was filed on 13 Jul 2026.
Current net transaction value: -$237,907.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002032351 Primary reporting owner

Bruls Annette

Relationship: CVP, EMEACLA
Address: ONE EDWARDS WAY, IRVINE
Signature: Linda J. Park, Attorney-in-Fact
Signature date: 28 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EW transaction

Common Stock

Sale

Transaction value: $237,907
Shares: -2,644
Change %: -13%
Price: $89.98
Shares after: 17,984
Date: 28 Aug 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.